#ipo-plans

#ipo-plans

Yuzu Health has raised $35M in Series A funding, led by General Catalyst and Chemistry, with participation from Anthropic's Anthology Fund and others, totaling $40M in equity funding.

"I'm surprised by how neutral the rule was, when you think about the massive amount of lobbying there's been around it. It doesn't say certain assets are good or bad. Instead, it really focuses on making a rules-based framework instead of a litigation-based one."

Mega IPOs like OpenAI and SpaceX are creating a gravity well in the public markets, what that means for smaller companies waiting to go public and whether the IPO pipeline is actually reopening in 2026. They also dig into the growing tension inside software companies as AI agents begin to threaten seat based pricing models and what recent disclosures are quietly admitting about the competitive risks.

Eisen, an escheatment compliance platform that automates dormant account offboarding and unclaimed property reporting for regulated financial institutions, has raised $7.2M in funding according to a recent SEC filing.

Futures are exploding higher, as President Trump chose not to 'end civilization in Iran' and agreed to a two-week pause on attacks on Iran.

Anthropic sought explicit contractual restrictions to prevent its AI from being used for mass domestic surveillance or fully autonomous weapons. The Pentagon, in contrast, insisted it must be able to deploy contractor technology for any lawful purpose. Negotiations broke down, the Department of Defense moved to terminate the contract, and it designated Anthropic a supply chain risk, effectively restricting many government agencies and defense contractors from working with the company.